San Antonio Breast Cancer Symposium, Dec. 6-10
The annual San Antonio Breast Cancer Symposium was held from Dec. 6 to 10 in San Antonio and attracted approximately 8,000 participants from around the world, including medical oncologists, radiation oncologists, researchers, and other health care pr…
Learn MoreMany U.S. Women Must Travel Far to Get Mammograms
MONDAY, Dec. 19, 2022 (HealthDay News) — Many American women have to travel long distances to reach the nearest mammography center, a new study finds — raising questions about whether that keeps some from receiving breast cancer screening.Researcher…
Learn MoreLa Dra. Monica Bertagnolli, directora del NCI, revela que tiene un cáncer de mama
MIÉRCOLES, 14 de diciembre de 2022 (HealthDay News) — La nueva directora del Instituto Nacional del Cáncer (NCI) de EE. UU. ha recibido un diagnóstico de cáncer de mama. La Dra. Monica Bertagnolli anunció la noticia el miércoles, y señaló que su cán…
Learn MoreNational Cancer Institute Director Monica Bertagnolli Reveals She Has Breast Cancer
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — The new director of the U.S. National Cancer Institute (NCI) has been diagnosed with breast cancer. Monica Bertagnolli, M.D., announced the news Wednesday, saying the breast cancer was diagnosed early and h…
Learn MoreNational Cancer Institute Director Dr. Monica Bertagnolli Reveals She Has Breast Cancer
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — The new director of the U.S. National Cancer Institute (NCI) has been diagnosed with breast cancer.Dr. Monica Bertagnolli announced the news Wednesday, saying the breast cancer was diagnosed early and her p…
Learn MoreSABCS: Most Young Women With Breast Cancer Report Impact on Sexual Health
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Most women diagnosed with breast cancer before age 45 years report an impact to their sexual health, according to the results of a survey presented at the annual San Antonio Breast Cancer Symposium, held fr…
Learn MoreSABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For young women with early-stage hormone receptor (HR)-positive breast cancer (BC) desiring pregnancy, temporary interruption of endocrine therapy does not confer a greater short-term risk for recurrence th…
Learn MoreRisk-Reducing Medications Can Cut Breast Cancer Death Rates
TUESDAY, Dec. 13, 2022 (HealthDay News) — Risk-reducing medication can reduce the risk for breast cancer death in addition to lowering the risk for invasive breast cancer, according to a study published online Dec. 1 in the Journal of Clinical Oncolo…
Learn MoreUnas mejores imágenes permiten a más mujeres optar por una cirugía que conserve el seno
VIERNES, 9 de diciembre de 2022 (HealthDay News) — Hace mucho que la mastectomía es el estándar de atención para ciertas pacientes con un cáncer de mama, pero todavía podría ser más extensiva de lo que algunas mujeres necesitan, sugiere un estudio re…
Learn MoreSABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo
MONDAY, Dec. 12, 2022 (HealthDay News) — For patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS) of 11 to 25, adjuvant en…
Learn More